These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 11892721)
1. Extrapyramidal syndromes associated with selective serotonin reuptake inhibitors: a case-control study using spontaneous reports. Schillevoort I; van Puijenbroek EP; de Boer A; Roos RA; Jansen PA; Leufkens HG Int Clin Psychopharmacol; 2002 Mar; 17(2):75-9. PubMed ID: 11892721 [TBL] [Abstract][Full Text] [Related]
2. Extrapyramidal reactions following treatment with antidepressants: Results of the AMSP multinational drug surveillance programme. Mörkl S; Seltenreich D; Letmaier M; Bengesser S; Wurm W; Grohmann R; Bleich S; Toto S; Stübner S; Butler MI; Kasper S World J Biol Psychiatry; 2020 Apr; 21(4):308-316. PubMed ID: 31347932 [No Abstract] [Full Text] [Related]
3. Non-puerperal lactation associated with antidepressant drug use. Egberts AC; Meyboom RH; De Koning FH; Bakker A; Leufkens HG Br J Clin Pharmacol; 1997 Sep; 44(3):277-81. PubMed ID: 9296322 [TBL] [Abstract][Full Text] [Related]
4. Risk factors for extrapyramidal symptoms during treatment with selective serotonin reuptake inhibitors, including cytochrome P-450 enzyme, and serotonin and dopamine transporter and receptor polymorphisms. Hedenmalm K; Güzey C; Dahl ML; Yue QY; Spigset O J Clin Psychopharmacol; 2006 Apr; 26(2):192-7. PubMed ID: 16633151 [TBL] [Abstract][Full Text] [Related]
5. Extrapyramidal symptoms associated with antidepressants--a review of the literature and an analysis of spontaneous reports. Madhusoodanan S; Alexeenko L; Sanders R; Brenner R Ann Clin Psychiatry; 2010 Aug; 22(3):148-56. PubMed ID: 20680187 [TBL] [Abstract][Full Text] [Related]
6. Risk of serious extrapyramidal symptoms in patients with Parkinson's disease receiving antidepressant drugs: a pharmacoepidemiologic study comparing serotonin reuptake inhibitors and other antidepressant drugs. Gony M; Lapeyre-Mestre M; Montastruc JL; Clin Neuropharmacol; 2003; 26(3):142-5. PubMed ID: 12782916 [TBL] [Abstract][Full Text] [Related]
8. Drugs associated with restless legs syndrome: a case/noncase study in the French Pharmacovigilance Database. Perez-Lloret S; Rey MV; Bondon-Guitton E; Rascol O; Montastruc AJ; J Clin Psychopharmacol; 2012 Dec; 32(6):824-7. PubMed ID: 23131889 [TBL] [Abstract][Full Text] [Related]
9. Effect of date of drug marketing on disproportionality measures in pharmacovigilance: the example of suicide with SSRIs using data from the UK MHRA. Pariente A; Daveluy A; Laribière-Bénard A; Miremont-Salame G; Begaud B; Moore N Drug Saf; 2009; 32(5):441-7. PubMed ID: 19419238 [TBL] [Abstract][Full Text] [Related]
13. What can we learn from consumer reports on psychiatric adverse drug reactions with antidepressant medication? Experiences from reports to a consumer association. Vilhelmsson A; Svensson T; Meeuwisse A; Carlsten A BMC Clin Pharmacol; 2011 Oct; 11():16. PubMed ID: 22026961 [TBL] [Abstract][Full Text] [Related]
14. Severe adverse drug reactions of antidepressants: results of the German multicenter drug surveillance program AMSP. Degner D; Grohmann R; Kropp S; Rüther E; Bender S; Engel RR; Schmidt LG Pharmacopsychiatry; 2004 Mar; 37 Suppl 1():S39-45. PubMed ID: 15052513 [TBL] [Abstract][Full Text] [Related]
15. Association of Hyponatraemia and Antidepressant Drugs: A Pharmacovigilance-Pharmacodynamic Assessment Through an Analysis of the US Food and Drug Administration Adverse Event Reporting System (FAERS) Database. Mazhar F; Pozzi M; Gentili M; Scatigna M; Clementi E; Radice S; Carnovale C CNS Drugs; 2019 Jun; 33(6):581-592. PubMed ID: 30977109 [TBL] [Abstract][Full Text] [Related]
16. [Reports of suspected side effects of selective serotonin reuptake inhibitors in Belgium and The Netherlands]. Van Ermen AM; Ottervanger JP; Roisin T; Kurz X; Stricker BH Ned Tijdschr Geneeskd; 1996 Sep; 140(36):1817-20. PubMed ID: 8927144 [TBL] [Abstract][Full Text] [Related]
17. Risk of upper gastrointestinal bleeding and the degree of serotonin reuptake inhibition by antidepressants: a case-control study. Vidal X; Ibáñez L; Vendrell L; Conforti A; Laporte JR; Drug Saf; 2008; 31(2):159-68. PubMed ID: 18217791 [TBL] [Abstract][Full Text] [Related]
18. The risk of postpartum hemorrhage with selective serotonin reuptake inhibitors and other antidepressants. Salkeld E; Ferris LE; Juurlink DN J Clin Psychopharmacol; 2008 Apr; 28(2):230-4. PubMed ID: 18344737 [TBL] [Abstract][Full Text] [Related]
19. Selective serotonin reuptake inhibitor-related extrapyramidal symptoms in autistic children: a case series. Sokolski KN; Chicz-Demet A; Demet EM J Child Adolesc Psychopharmacol; 2004; 14(1):143-7. PubMed ID: 15142402 [TBL] [Abstract][Full Text] [Related]
20. Who develops severe or fatal adverse drug reactions to selective serotonin reuptake inhibitors? Dalfen AK; Stewart DE Can J Psychiatry; 2001 Apr; 46(3):258-63. PubMed ID: 11320680 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]